Lincare to pay $29M over false claims for improperly billing Medicare
By 
Jeff Dale2023-08-29T18:41:00
A Florida-based provider of oxygen equipment for patients with respiratory ailments agreed to pay $29 million to resolve allegations it violated the False Claims Act by fraudulently overbilling Medicare.
Lincare Holdings, a subsidiary of German multinational chemical corporation Linde, admitted to improperly billing Medicare, Medicare Advantage plans, and beneficiaries for leased oxygen equipment the company had already been reimbursed for by the government, U.S. Attorney for the Eastern District of Washington Vanessa Waldref announced in a press release Monday.
The settlement resolves a lawsuit brought under the qui tam provisions of the False Claims Act by two former Lincare employees, Benjamin Montgomery and Brandon Haugen, who will receive more than $5.6 million.
Related articles
-
News BriefLincare to pay $26M over Medicare billing violations
Lincare, a supplier of durable medical equipment, agreed to pay $25.5 million to settle allegations it billed federal health programs for the rental of ventilator machines after patients no longer needed to use them.
-
News BriefCardiac Imaging, CEO to pay $85M in DOJ false claims case
Cardiac Imaging and its chief executive agreed to pay a total of more than $85 million to settle charges levied by the Department of Justice addressing alleged violations of the False Claims Act regarding unlawful kickbacks.
-
News BriefDOJ orders Cigna to pay $172M over false claims to Medicare
Multinational health insurance company Cigna agreed to pay more than $172 million as part of a settlement with the Department of Justice addressing allegations it submitted and failed to withdraw false claims to Medicare.
More from Regulatory Enforcement
-
ArticleDOJ dismisses indictment against Cassava advisor amid legal flaws
The DOJ dropped a June 2024 indictment against a Cassava Sciences advisor, closing a case tied to an alleged short-selling scheme and related government probes. The case was criticized for fundamental flaws in evidence and legal procedures.
-
ArticleFormer Capula CCO alleges misconduct and retaliation at the hedge fund firm
The former U.S. chief compliance officer of hedge fund firm Capula Investment Management has blown the whistle against his former employer, alleging he was terminated for raising concerns about improper expensing practices.
-
ArticleFINRA fines First Trust $10M for allegedly giving too-generous gifts to brokers
First Trust Portfolios has been fined $10 million by FINRA for allegedly providing excessive meals, gifts, and other incentives to broker-dealers.